Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines

Life Sciences

Volumn 59, Issue 17, 1996, Pages 1389-1400

  Venugopal, Meenakshi ^a,b   Jamison, James M ^a,b,d   Gilloteaux, Jacques ^c   Koch, John A ^a,b   Summers, Marcia ^a,b   Giammar, David ^a,b   Sowick, Colleen ^a,b   Summers, Jack L ^a,b  

^a SUMMA HEALTH SYSTEM   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d Northeastern Ohio Medical University   (United States)

Author keywords

bladder; menadione; prostate; urologic neoplasms; vitamin C

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; CATALASE; DNA; HYDROGEN PEROXIDE; MENADIONE; PROTEIN; REACTIVE OXYGEN METABOLITE; TETRAZOLIUM; THIOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; URINARY TRACT CANCER;

EID: 0030595066     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00466-3     Document Type: Article

References (36)

1. 1. S.L. PARKER T. TONG, S. BOLDEN and PA. WINGO, CA Cancer J. Clin. 65, 5-27 (1996).
2. 2. W.U. SHIPLEY, G.R. PROUT and D.S. KAUFMAN, Cancer 65, 675-683 (1990).
3. 3. C. MAHLER and L. DENIS, Cancer 70, 332-334 (1992).
4. 4. K. PAVELIC, Z. KOS and S. SPAVENTI, Int. J. Biochem. 21, 931-935 (1989).
5. 5. V. NOTO, H.S. TAPER, Y.H. JIANG, J. JANSSENS, J. BONTE and W. DE LOECKER, Cancer 63, 901-906 (1989).
6. 6. F.Y-H. WU, W-C. LIAO and H-M. CHANG, Life Sci. 52, 1797-1804 (1993).
7. 7. L.M. NUTTER, A.L. CHENG, H.L. HUNG, R.K. HSIEH, E.O. NGO and T.W. Liu, Biochem. Pharmacol. 41, 1283-1292 (1991).
8. 8. H.S. TAPER, J. DE GERLACHE, M. Lans and M. Roberfroid, Int. J. Cancer 40, 575-579 (1987).
9. 9. J. GILLOTEAUX, J.M. JAMISON, M. VENUGOPAL, D. GIAMMAR and J.L. SUMMERS, Scanning Microsc. 9, 159-173 (1995).
10. 10. R.R. SOKAL and F.J. ROHLF, in Introduction to Biostatistics, W.H. Freeman and Company, San Francisco, p.103 (1973).
11. 11. J. SUHNEL, Antiviral Res. 13, 23-39 (1990).
12. 12. K. NITAHARA, A. KITTEL, S.D. LIANG and E.S. VIZI, Neuroscience 67, 159-168 (1995).
13. 13. M.M. BRADFORD, Anal. Biochem. 72, 248-254 (1976).
14. 14. E.M. SHEVACH, in Current Protocols in Immunology, Vol II, J.E. COLIGAN, A.M. KRUISBEEK, D.H. MARGULIES, E.M. SHEVACH and W. STROBER (eds.), John Wiley & Sons, New York, A.3.8 (1994).
15. 15. P. MENE, A. TARANTA, F. PUGLIESE, G. CINOTTI and A. D'AGOSTINO, J. Lab. Clin. Med. 120, 48-56 (1992).
16. 16. J.F. NAGELKERKE, P. DOGTEROM, H.J.G.M. DE BONT and G.J. MULDER, Biochem. J. 263, 347-353 (1989).
17. 17. T.W. GANT, D.N. RAO, R.P. MASON and G.M. COHEN, Chem. Biol. Interact. 65, 157-173 (1988).
18. 18. F. MIRABELLI, A. SALIS, M. VAIRETTI, G. BELLOMO, H. THOR and S. ORRENIUS, Arch. Biochem. Biophys. 270, 478-488 (1989).
19. 19. G. BELLOMO, S.A. JEWELL and S. ORRENIUS, J. Biol. Chem. 257, 11558-11562 (1982).
20. 20. C.R. STUBBERFIELD and G.M. COHEN, Biochem. Pharmacol. 38, 2631-2637 (1989).
21. 21. S. BRAM, P. FROUSSARD, M. GUICHARD, C. JASMIN, Y. AUGERY, F., SINOUSSIBARRE and W. WRAY, Nature (Lond.) 284, 629-613 (1980).
22. 22. C.H. PARK, M. AMARE, M.A. SAVIN and B. HOOGSTRATEN, Cancer Res. 40, 1062-1065 (1980).
23. 23. K.N. PRASAD, P.K. SINHA, M. RAMANUJAM and A. SAKAMOTO, Proc. Natl. Acad. Sci., USA 76, 829-832 (1979).
24. 24. F.S. LIOTTI, A.R. MENGHINI, P. GUERRIERI, V. TALSEA and M. BODO, J. Cancer Res. 108, 230-232 (1984).
25. 25. P.Y. LEUNG, K. MIYASHITA, M. YOUNG, and C.S. TSAO, Anticancer Res. 13, 475-480 (1993).
26. 26. V. DE LAURENZI, G. MELINO, I. SAVINI, M. ANNICCHIARICO-PETRUZZELLI, A. FINAZZI-AGRO and L. AVIGLIANO, Eur. J. Cancer 31, 463-466 (1995).
27. 27. F.Y-H. WU, N.-T. CHANG, W.-J. CHEN and C.-C. JUAN, Oncogene 8, 2237-2244 (1993).
28. 28. K.A. MARGOLIN, S.A. AKMAN, L.A. LEONG, R.J. MORGAN, G. SOMLO, J.W. RASCHKO, C. AHN and J.H. DOROSHOW, Cancer Chem. Pharm. 36, 293-298 (1995).
29. 29. M. TETEF, K. MARGOLIN, C. AHN, S. AKMAN, W. CHOW, L. LEONG, R.J. MORGAN, J. RASCHKO, G. SOMLO and J.H. DOROSHOW, Invest. New Drugs 13, 157-162 (1995).
30. 30. C-C. JUAN and F.Y.-H. WU,O Biochem. Biophys. Res. Commun. 190, 907-913 (1993).
31. 31. D.J. McCONKEY, P. HARTZELL, P. NICOTERA, A.H. WYLLIE and S. ORRENIUS, Toxicol. Lett. 42, 123-130 (1988).
32. 32. H.S. TAPER and M. ROBERFROID, Anticancer Res. 12, 1651-1654 (1992).
33. 33. J.M. JAMISON, J. GILLOTEAUX, M. VENUGOPAL, J.A. KOCH, C. SOWICK, R. SHAH and J.L. SUMMERS, Tissue Cell (in press)
34. 34. J.M. DYPBUKT, M. ANKERONA, M. BURKITT, Å SJOHOLM, K STROM, S. ORRENIUS and P. NICOTERA, J. Biol. Chem. 269, 30553-30560 (1994).
35. 35. R. JARABEK and J. JARABEK, Arch. Biochem. Biophys. 318, 418-423 (1995).
36. 36. H. THOR, M.T. SMITH, P. HARTZELL, G. BELLOMO, S.A. JEWELL and S. ORRENIUS, J. Biol. Chem. 257, 12419-12425 (1982).